[Fibrinolytic properties of human tissue and pathogenesis of hyperfibrinolysis in thrombohemorrhagic syndrome].
D000236:Adenoma; D000347:Afibrinogenemia / Q000209:etiology; D000653:Amniotic Fluid / Q000032:analysis; D001778:Blood Coagulation Disorders / Q000209:etiology*; D001921:Brain; D005260:Female; D005342:Fibrinolysis; D006470:Hemorrhage / Q000209:etiology; D006801:Humans; D007668:Kidney / Q000032:analysis; D008099:Liver / Q000032:analysis; D008168:Lung / Q000032:analysis; D008297:Male; D009132:Muscles / Q000032:analysis; D009206:Myocardium; D010179:Pancreas / Q000032:analysis; D010537:Peritoneum; D010538:Peritonitis; D010994:Pleura / Q000032:analysis; D011247:Pregnancy; D011467:Prostate / Q000032:analysis; D011471:Prostatic Neoplasms; D012867:Skin / Q000032:analysis; D013927:Thrombosis / Q000209:etiology*; D014599:Uterus
Fibrinoliticheskie svoĭstva tkaneĭ cheloveka i patogenez giperfibrinoliza pri trombohemorragicheskom sindrome.